Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP797556.RAIsgySUFBxfV7-QEHz6Y-x89PfUA_HswfxKFp8zoYzIQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP797556.RAIsgySUFBxfV7-QEHz6Y-x89PfUA_HswfxKFp8zoYzIQ130_assertion type Assertion NP797556.RAIsgySUFBxfV7-QEHz6Y-x89PfUA_HswfxKFp8zoYzIQ130_head.
- NP797556.RAIsgySUFBxfV7-QEHz6Y-x89PfUA_HswfxKFp8zoYzIQ130_assertion description "[Treatment duration in patients with chronic hepatitis C in the era of standard interferon-alpha plus ribavirin was tailored according to hepatitis C virus (HCV) genotype: patients infected with HCV-1 were treated for 48 weeks, patients infected with HCV-2/3 for 24 weeks.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP797556.RAIsgySUFBxfV7-QEHz6Y-x89PfUA_HswfxKFp8zoYzIQ130_provenance.
- NP797556.RAIsgySUFBxfV7-QEHz6Y-x89PfUA_HswfxKFp8zoYzIQ130_assertion evidence source_evidence_literature NP797556.RAIsgySUFBxfV7-QEHz6Y-x89PfUA_HswfxKFp8zoYzIQ130_provenance.
- NP797556.RAIsgySUFBxfV7-QEHz6Y-x89PfUA_HswfxKFp8zoYzIQ130_assertion SIO_000772 15158341 NP797556.RAIsgySUFBxfV7-QEHz6Y-x89PfUA_HswfxKFp8zoYzIQ130_provenance.
- NP797556.RAIsgySUFBxfV7-QEHz6Y-x89PfUA_HswfxKFp8zoYzIQ130_assertion wasDerivedFrom befree-20140225 NP797556.RAIsgySUFBxfV7-QEHz6Y-x89PfUA_HswfxKFp8zoYzIQ130_provenance.
- NP797556.RAIsgySUFBxfV7-QEHz6Y-x89PfUA_HswfxKFp8zoYzIQ130_assertion wasGeneratedBy ECO_0000203 NP797556.RAIsgySUFBxfV7-QEHz6Y-x89PfUA_HswfxKFp8zoYzIQ130_provenance.